Clinical TrialID 856

Effects of Berries and Berry Fractions on Metabolic Diseases

NCT01860547

Type 2 Diabetes|Atherosclerosis

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
856
Evidence Id
856
Core Evidence Id
856
Source Clinical Trial Id
838
Herb2 Clinical Trial Id
HBCT000838
Nct Id
NCT01860547
Title
Effects of Berries and Berry Fractions on Metabolic Diseases
Status
Completed
Phase
Study Result
No
Study Condition
Type 2 Diabetes|Atherosclerosis
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: PREVENTION
Intervention
DIETARY_SUPPLEMENT: Bilberries|DIETARY_SUPPLEMENT: Sea buckthorn berry|DIETARY_SUPPLEMENT: Sea buckthorn phenolic extract|DIETARY_SUPPLEMENT: Sea buckthorn oil
Intervention Allocation
Randomized
Intervention Model
Crossover
Intervention Mask
Intervention Purpose
Prevention
Gender
Female
Age
Adult
Enrollment
110
Outcome Measure
Serum Alanine aminotransferase (ALAT), Change from beginnig to end of each berry treatment (duration of treatments average 33-35 days)
Sponsor Collaborator
University of Turku|Pakkasmarja|Saarioinen|Kiantama Ltd.|Aromtech Ltd.|Fazer|Satakunta Sea Buckthorn Society|Finnish Berry Powders Ltd.
Funded By
OTHER
Location
University of Turku, Dept of Biochemistry and Food Chemistry, Turku, FI-20014, Finland
Other Id
TYBID1
Start Date
2008-06
Primary Completion Date
2009-06
Completion Date
2009-08
First Posted
2013-05-22
Results First Posted
Last Update Posted
2013-05-22
Study Document
Study Url
https://clinicaltrials.gov/study/NCT01860547
Title Cn
Title En
Effects of Berries and Berry Fractions on Metabolic Diseases
Bilingual Status
semi_complete